Evidence map›Paper›PMID 26460219›Full record

ArticleMolecular medicine reports2015

Role of the Toll‑like receptor 3 signaling pathway in the neuroprotective effect of sevoflurane pre‑conditioning during cardiopulmonary bypass in rats.

Jin Zhou, Nan Zhou, Xiao-Ning Wu, Hui-Juan Cao, Ying-Jie Sun, Tie-Zheng Zhang, Ke-Yan Chen, Dong-Mei Yu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jin ZhouDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Nan ZhouDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Xiao-Ning WuDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Hui-Juan CaoDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Ying-Jie SunDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Tie-Zheng ZhangDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Ke-Yan ChenDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
Dong-Mei YuDepartment of Anaesthesiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110015, P.R. China.
General Hospital of Shenyang Military Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to explore the roles and possible molecular mechanism of the alleviating effect of sevoflurane pre‑treatment on the extracorporeal circulation and to investigate the possible involvement of the Toll‑like receptor (TLR3) signaling pathway. A total of 64 male Sprague Dawley rats were randomly divided into three groups: The sham operation group (H group; n=8), cardiopulmonary bypass (CPB) group (C group; n=24) and sevoflurane pre‑conditioning group (S group; n=32). The C group was subjected to tracheal intubation and mechanical ventilation, vessel puncture and catheter placement in the right femoral artery and right internal jugular vein, while no CPB was performed in the H group. The S group was pre‑treated with 2.4% sevoflurane for 1 h prior to establishing the CPB model. The CPB in the C and S groups was performed for 1 h. Blood of the rats was analyzed and clinical parameters were detected prior to, during and at various time‑points after CPB. In addition, eight rats from the C and S groups each were sacrificed at these time‑points and brain tissue samples were analyzed. The levels of the brain damage‑specific protein S100‑β as well as IL‑6 and IFN‑β in the serum were detected by ELISA; furthermore, the expression levels of TLR3 and TIR‑domain‑containing adapter‑inducing interferon‑β (TRIF) in the left hippocampus were assessed by ELISA and/or western blot analysis. The right hippocampus was assessed for neuronal apoptosis by terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The mean arterial pressure, heart rate and hematocrit were significantly decreased following CPB (P<0.05), while there was no significant changes in any other clinical parameters. The serum levels of S100‑β and IL‑6 in the C group were significantly increased compared with those in the H group (P<0.05), which was attenuated by sevoflurane‑pre‑treatment. Compared with the H group, the serum levels of IFN‑β as well as hippocampal protein levels of TLR3 and TRIF were significantly increased in the C group during and after CPB (P<0.05), which was markedly aggravated in the S group (P<0.05). The number of apoptotic hippocampal neurons, although being generally low, was significantly increased in the C group compared with that in the H group (P<0.05), while apoptosis was significantly attenuated by sevoflurane‑pre‑treatment (P<0.05). The present study therefore concluded that 2.4% sevoflurane pre‑treatment has a protective effect on the rat brain against CPB‑induced injury, which may be mediated via the TLR3 signaling pathway through upregulating the expression levels of anti‑inflammatory and downregulating pro‑inflammatory proteins.

Indexed as

Ischemic Preconditioning, MyocardialSignal TransductionAnimalsBiomarkersBlood Gas AnalysisCardiopulmonary BypassExtracorporeal CirculationHippocampusInterferon-betaInterleukin-6MaleMethyl EthersNeuroprotective AgentsRandom AllocationRatsRats, Sprague-DawleyBiomarkersInterferon-betaInterleukin-6Methyl EthersNeuroprotective AgentsS100b protein, ratS100 Calcium Binding Protein beta SubunitSevofluraneToll-Like Receptor 3

Identifiers

PMID26460219
PMCPMC4758330
OpenAlexW1942035201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.